Showing 2551-2560 of 3241 results for "".
- Vehicles, Infectious Disease, and Acne Updates from Day 2 at DERM2019https://practicaldermatology.com/news/vehicles-infectious-disease-and-acne-updates-from-day-2-at-derm2019/2460099/The DERM2019 NP/PA CME Conference continued to delight audiences with esteemed faculty presenters, including those who presented Friday, including April Armstrong, David Cohen, Kara Gooding, Joseph Gorelick, Julie Harper, Jayme Heim, George Keough, Leon Kircik, Kristine Kucera, Gilly Munavalli, T
- Study Highlights Need for Tailored Skin Cancer Prevention Strategieshttps://practicaldermatology.com/news/study-highlights-need-for-tailored-skin-cancer-prevention-strategies/2460090/Sun safety practices for attendees at skin cancer screening events differ from the general public, according to findings published by researchers from the George Washington University (GW) Cancer Center. The study appears in the
- LEO Pharma Completes Acquisition of Bayer’s Prescription Dermatology Businesshttps://practicaldermatology.com/news/leo-pharma-completes-acquisition-of-bayers-prescription-dermatology-business/2460086/LEO Pharma and Bayer announced the achievement of the relevant closing conditions to allow the transfer of Bayer’s global prescription dermatology business to LEO Pharma. The companies first announced the proposed transaction on July 31, 2018 and completed the first step of the acquisition
- Hair Loss Breakthrough: 3D-Printing Creates “Hair Farms”https://practicaldermatology.com/news/hair-loss-breakthrough-research-uses-3d-printing-to-create-hair-farms/2460083/Columbia researchers have created a way to use 3-D printing to create “hair farms” in a dish, which could open up hair restoration surgery to more people, including women, and improve the way pharmaceutical companies search for new hair growth drugs. The findings, which appe
- BioPharmX’s BPX-04 Performs Well in Rosacea Trialhttps://practicaldermatology.com/news/biopharmxs-bpx-04-performs-well-in-rosacea-trial/2460078/BioPharmX Corporation ‘s BPX-04, a novel topical gel formulation of fully solubilized minocycline for the treatment of moderate-to-severe papulopustular rosacea, performed well in a Phase 2b clinical trial, the Company reports. In the trial,
- New Data Support Clinical Utility of DermTech's PLAhttps://practicaldermatology.com/news/new-data-support-clinical-utility-of-dermtechs-pla/2460074/A new clinical study confirms the clinical utility of the DermTech’s pigmented lesion assay (PLA)in the early detection of melanoma. The PLA is a non-invasive test that uses molecular gene expression to identify malignant changes in a skin sample collected with adhesive
- Joanna Zucker is New CEO at PCA Skinhttps://practicaldermatology.com/news/joanna-zucker-is-new-ceo-at-pca-skin/2460071/With more than 25 years of experience in Consumer Packaged Goods and Retail, Joanna Zucker is assuming the role of Chief Executive Officer for PCA SKIN, part of Colgate-Palmolive's professional skin care portfolio. Ms. Zucker previously served in senior management and marketing
- Sciton Promotes Two Leadershttps://practicaldermatology.com/news/sciton-promotes-two-leaders/2460050/Bryant Wong is the new Vice President of Finance at Sciton and Emma Haaland is the new Global Director of Customer Service. Mr. Wong spent two years as the leader of the finance department at Sciton. He worked for nearly 12 years with PricewaterhouseCoopers and Deloitte C
- Constellation Alpha Capital Corp. to Merge with DermTech, Inc.https://practicaldermatology.com/news/constellation-alpha-capital-corp-to-merge-with-dermtech-inc/2460041/Constellation Alpha Capital Corp. is merging with DermTech, Inc., a molecular genomics company with an initial focus on skin cancer. "DermTech has developed a deep pipeline of dermatology-focused dia
- FDA Approves Sorilux for Adolescent Plaque Psoriasishttps://practicaldermatology.com/news/fda-approves-sorilux-for-adolescent-plaque-psoriasis/2460039/The FDA has approved Mayne Pharma Group Limited's Sorilux (calcipotriene) Foam, 0.005% in adolescents 12 years and older. The FDA approved Sorilux in 2010 based on evidence from two eight-week placebo controlled clinical trials in patients with mild to moderate plaque psoriasis of t